2Keeble JE,Moore PK.Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs J].Br J Pharmacol,2002,137 (3):295-310.
3Ignarro LJ,Napoli C,Loscalzo J.Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide[J].Circ Res.2002,90 (1):21-28.
4Burgaud JL,Riffaud JP,Del Soldato P.Nitric-oxide releasing molecules:a new class of drugs with several major indications[J].Curr Pharm Des,2002,8(3):201-213.
5Carini M,Aldini G,Stefani R,et al.Nitrosylhemoglobin,an unequivocal index of nitric oxide release from nitroaspirin:in vitro and in vivo studies in the rat by ESR spectroscopy[J].J Pharm Biomed Anal.2001,26 (4):509-518.
6Burgaud JL,Ongini E,Soldato PD.Nitric oxide-releasing drugs A novel class of effective and safe therapeutic agents[J].Ann N Y Acad Sci,2002,962(5):360-371.
7Fiorucci S,Del Soldato P.NO-aspirin:mechanism of action and gastrointestinal safety[J].Dig Liver Dis,2003,35(Suppl 2):S9-S19.
8Fiorucci S,Santucci L,Wallace JL,et al.Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NOreleasing aspirin in the human gastric mucosa[J].PNAS,2003,100(19):10937-10941.
9Al-Swayeh OA,Clifford RH,Del Soldato P,et al.A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin[J].Br J Pharmacol,2000,129(2):343-350.
6Xiao ZS,QuarlesLD,Cben QQ,et al.Effcet of asymmetlh dimel by lalginiue on osteoblastit diffemnlialion[J].Kidney-lnt,2001,60(5):1699-1704.
7Nonmra S.rakano.Yamamoto T Molecular revent caused by machanieal stress in bone[J].Matrix Bi,2000,19(2):91-96.
8Ann Marie Simon,BS,J.Patrick O’Connor,PhD.Dose and Time-Dependent Effects of Cyclooxygenase-2Inhibition on Fracture-Healing[J].THE JOURNAL OF BONE&JOINT SURGERY·JBJS.ORG,2007,89-A(3):500-511.
9Carlni M,Aldini G,Stefani R,et al.Nitrosylhemoglobin,an unequivocal index of nitric oxide release from ni.troaspirin:in vitro and in vivo studies in the rat by ESRspectroscopy[J].J Pharm Biomed Anal,2001,26(4):509-518.
10Armour KJ,Vanl Hof RJ,2hInour KE,et al.Inhibition of bone resorption in vitro and prevention of ovafiectemy induced bone loss in vivo by flurbiprofen nitroxybutylester(HCTl026)[J].Arthritis Rhettm,2001,44(9):2185-2192.
